Search Results Search Sort by RelevanceMost Recent Medicine and Society Dec 2019 An Exclusive Interview With CRISPR Sean C. McConnell, PhD Clinically and ethically relevant questions are related to patient safety, therapeutic efficacy, equitable access, and global governance over humanity’s genetic legacy. AMA J Ethics. 2019;21(12):E1079-1088. doi: 10.1001/amajethics.2019.1079. Art of Medicine Dec 2019 Sunset Antonio Yaghy, MD This image aims to promote reflection about patients’ feelings of sadness, despair, helplessness, and uncertainty upon being diagnosed. AMA J Ethics. 2019;21(12):E1103-1104. doi: 10.1001/amajethics.2019.1103. In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. AMA Code Says Dec 2018 AMA Code of Medical Ethics’ Opinions Related to a Physician’s Power to Name Scott J. Schweikart, JD, MBE The Code offers guidance about delivering a diagnosis and promoting patients’ best interests when assigning names to patients’ conditions. AMA J Ethics. 2018;20(12):E1139-1142. doi: 10.1001/amajethics.2018.1139. Original Research Feb 2019 Can AI Help Reduce Disparities in General Medical and Mental Health Care? Irene Y. Chen, Peter Szolovits, PhD, and Marzyeh Ghassemi, PhD As machine learning becomes increasingly common in health care, these systems’ data, algorithms, and recommendations raise critical justice questions. AMA J Ethics. 2019;21(2):E167-179. doi: 10.1001/amajethics.2019.167. Medicine and Society Jun 2016 Ethical and Epidemiological Dimensions of Labeling Psychosis Risk Cheryl M. Corcoran, MD Although the stigma of the psychosis risk label can cause harm, the label can also confer benefit and provides an explanatory framework for symptoms. AMA J Ethics. 2016;18(6):633-642. doi: 10.1001/journalofethics.2016.18.6.msoc2-1606. Art of Medicine Feb 2020 Risks, Benefits, and Conundrums of Cancer Screening Nick Love, PhD A patient’s story represents an ethical dilemma of cancer screening: it can save lives but generates diagnostic morbidity and incurs costs. AMA J Ethics. 2020;22(2):E164-165. doi: 10.1001/amajethics.2020.164. Case and Commentary Mar 2020 How Should Organizations Respond to Repeated Noncompliance by Prominent Researchers? Min-Fu Tsan, MD, PhD and Grace L. Tsan, OD IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations. AMA J Ethics. 2020;22(3):E201-208. doi: 10.1001/amajethics.2020.201. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Current page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Medicine and Society Dec 2019 An Exclusive Interview With CRISPR Sean C. McConnell, PhD Clinically and ethically relevant questions are related to patient safety, therapeutic efficacy, equitable access, and global governance over humanity’s genetic legacy. AMA J Ethics. 2019;21(12):E1079-1088. doi: 10.1001/amajethics.2019.1079.
Art of Medicine Dec 2019 Sunset Antonio Yaghy, MD This image aims to promote reflection about patients’ feelings of sadness, despair, helplessness, and uncertainty upon being diagnosed. AMA J Ethics. 2019;21(12):E1103-1104. doi: 10.1001/amajethics.2019.1103.
In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
AMA Code Says Dec 2018 AMA Code of Medical Ethics’ Opinions Related to a Physician’s Power to Name Scott J. Schweikart, JD, MBE The Code offers guidance about delivering a diagnosis and promoting patients’ best interests when assigning names to patients’ conditions. AMA J Ethics. 2018;20(12):E1139-1142. doi: 10.1001/amajethics.2018.1139.
Original Research Feb 2019 Can AI Help Reduce Disparities in General Medical and Mental Health Care? Irene Y. Chen, Peter Szolovits, PhD, and Marzyeh Ghassemi, PhD As machine learning becomes increasingly common in health care, these systems’ data, algorithms, and recommendations raise critical justice questions. AMA J Ethics. 2019;21(2):E167-179. doi: 10.1001/amajethics.2019.167.
Medicine and Society Jun 2016 Ethical and Epidemiological Dimensions of Labeling Psychosis Risk Cheryl M. Corcoran, MD Although the stigma of the psychosis risk label can cause harm, the label can also confer benefit and provides an explanatory framework for symptoms. AMA J Ethics. 2016;18(6):633-642. doi: 10.1001/journalofethics.2016.18.6.msoc2-1606.
Art of Medicine Feb 2020 Risks, Benefits, and Conundrums of Cancer Screening Nick Love, PhD A patient’s story represents an ethical dilemma of cancer screening: it can save lives but generates diagnostic morbidity and incurs costs. AMA J Ethics. 2020;22(2):E164-165. doi: 10.1001/amajethics.2020.164.
Case and Commentary Mar 2020 How Should Organizations Respond to Repeated Noncompliance by Prominent Researchers? Min-Fu Tsan, MD, PhD and Grace L. Tsan, OD IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations. AMA J Ethics. 2020;22(3):E201-208. doi: 10.1001/amajethics.2020.201.